
Recent developments with Heron Therapeutics Inc (HRTX) have led to the company’s beta value being reach 1.24 cents.
On Friday, Heron Therapeutics Inc (NASDAQ: HRTX) was -28.26% drop from the session before settling in for the closing price of $1.84. A 52-week range